These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cerebral infarction as first manifestation of thrombocytopenia caused by pentosan polysulfate]. Gironell A; Arboix A; Altés A; Martí-Vilalta JL Med Clin (Barc); 1997 Apr; 108(16):636. PubMed ID: 9303962 [No Abstract] [Full Text] [Related]
4. Epidural hematoma after epidural steroid injection: a possible association with use of pentosan polysulfate sodium. Siddiqui MN; Ranasinghe JS; Siddiqui S Anesthesiology; 2001 Nov; 95(5):1307. PubMed ID: 11685018 [No Abstract] [Full Text] [Related]
5. Large Subfoveal Vitelliform Lesions in a Case of Pentosan Polysulfate Maculopathy. Wannamaker KW; Sisk RA Ophthalmology; 2020 Dec; 127(12):1641. PubMed ID: 33222775 [No Abstract] [Full Text] [Related]
18. Direct transition from hypo- to hyperkalaemic paralysis during potassium treatment of familial periodic paralysis. A case. Sestoft L Dan Med Bull; 1967 Jun; 14(7):157-60. PubMed ID: 6047305 [No Abstract] [Full Text] [Related]
20. Use of corticotropin-induced potassium changes in the diagnosis of both hypo- and hyperkalemic periodic paralysis. Streeten DH; Speller PJ; Fellerman H Eur Neurol; 1993; 33(2):103-8. PubMed ID: 8385612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]